Community pharmacy loyalty among individuals with schizophrenia

BackgroundCommunity pharmacists can use medication records to assist individuals who are loyal to their pharmacy in better managing their pharmacotherapy. However, the extent of community pharmacy loyalty among individuals with severe mental illness such as schizophrenia remains unknown.ObjectiveTo assess the extent of community pharmacy loyalty among individuals with schizophrenia and identify factors associated with loyalty.MethodsUsing the Quebec Health Insurance Board databases, a cohort study of individuals with schizophrenia who claimed an antipsychotic drug for the first time between January 1, 2001 and December 31, 2005 was conducted. Such individuals were considered loyal to their community pharmacy if they filled all their prescriptions for any drug at the same community pharmacy during the second year after antipsychotics initiation. Logistic regression models were used to identify factors associated with community pharmacy loyalty (measured in the first year after antipsychotics initiation).ResultsOf the 6159 individuals in the study, 57.8% were loyal to one pharmacy. Men were more likely to be loyal (Adjusted OR = 1.29; 95% CI = 1.16–1.44), as were individuals aged 30–64 years and those aged ≥65 years, when compared to individuals 20–29 years (1.70; 1.48–1.95 and 2.39; 1.97–2.90, respectively). Individuals who filled their antipsychotics on a weekly basis were also more likely to be loyal (1.39; 1.18–1.63). Factors associated with non-loyalty were welfare beneficiary status (0.79; 0.70–0.89), having substance-use disorder (0.69; 0.60–0.80), a greater number of different types of drugs (5–8 types = 0.76; 0.66–0.87; 9–51 = 0.59; 0.50–0.69), and emergency department visits (0.71; 0.60–0.82).ConclusionsResults suggest that medication records in community pharmacies are incomplete for 42.2% of individuals with schizophrenia. Individuals more likely to experience more severe illness were also those less likely to be loyal. Given the potentially severe consequences of medication-related problems in this latter population, strategies to further improve the comprehensiveness of medication information should be promoted.